Hassman Research Institute

Single-Dose Psilocybin Treatment for Major Depressive Disorder

Charles L. Raison, Gerard Sanacora, Joshua Woolley et al. · JAMA · 2023 · 423 citations · Full text

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab

John D. Davis, Ashish Bansal, David Hassman et al. · Clinical Pharmacology & Therapeutics · 2018 · 45 citations · Full text

Allergy Medicine, Skin Allergy, Pharmacotherapy +16

Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials

Inder Kaul, Sharon Sawchak, Amy Claxton et al. · Schizophrenia · 2024 · 23 citations · Full text

Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia

Elan A. Cohen, Taisa Skubiak, Dusica Hadzi Boskovic et al. · The Journal of Clinical Psychiatry · 2022 · 17 citations · Full text

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study

David P. Walling, Howard A Hassman, Lourdes Anta et al. · Drug Design Development and Therapy · 2021 · 16 citations · Full text